Craft

Advanced
PulseSight

PulseSight

Total Funding

$40.1 M

PulseSight Summary

Company Summary

Overview
PulseSight Therapeutics (formerly known as Eyevensys) is a biotechnology company that develops an EyeCET platform to enable the sustained intraocular production of therapeutic proteins to treat ophthalmic diseases. Its platform allows the ciliary muscle cells to sustainably produce therapeutic proteins locally.
Type
Private
Status
Active
Founded
2008
HQ
Paris, FR | view all locations
Website
https://pulsesight.com/
Cybersecurity rating
Sectors

Table of Contents

Key People

  • Francine Behar-Cohen

    Francine Behar-Cohen, Founder, Chief Innovation Officer

    • Johannes Zanzinger

      Johannes Zanzinger, Director

      • Patricia Zilliox

        Patricia Zilliox, President and CEO

        • Dominik Escher

          Dominik Escher, Director

          LocationsView all

          3 locations detected

          • Paris, Île-de-France HQ

            France

            33 Avenue du Maine

          • Cambridge, MA

            United States

            185 Alewife Brook Pkwy Ste 210

          • Paris, IDF

            France

            11 Rue Watt bat b

          Competitors and Similar Companies

          Compare competitors

          Footer menu

          Product

          Solutions

          Resources

          Company

          © Craft.co 2025
          Share price data provided by IEX